The board of directors of China Regenerative Medicine International Limited announced that Mr. Chan Bing Woon ("Mr. Chan") has tendered his resignation as an independent non-executive Director with effect from 15 August 2019 as he would like to focus on the provision of mediation services. Upon Mr. Chan's resignation, Mr. Chan will cease to act as a member of each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board. Mr. Chan has confirmed that he has no disagreement with the Board and that there are no other matters in relation to his resignation that needs to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited (the "Stock Exchange").